|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.99 HKD | -3.40% |
|
-5.24% | -21.96% |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. provided earnings guidance for the year ended December 31, 2012. The board of directors of the company and its subsidiaries are expected to record a substantial increase in profits for the year ended December 31, 2012 as compared to the profits in the year 2011.
Such increase in profits is mainly attributable to the significant increase in the company's sales during such period.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.96% | 792M | |
| +16.20% | 78.51B | |
| +13.10% | 9B | |
| +42.06% | 4.96B | |
| -14.54% | 4.84B | |
| +9.01% | 3.72B | |
| +21.94% | 2.48B | |
| -27.22% | 2.19B | |
| +15.83% | 2.12B | |
| -39.50% | 1.94B |
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD. 
